Bundibugyo Ebola Diagnostics and Global Outbreak Preparedness
Article Sidebar
Main Article Content
Abstract
In this interview, Alan L. Landay and Michael M. Lederman speak with Gene Olinger and Thomas Ksiazek about the ongoing Bundibugyo Ebola outbreak and the broader challenges of epidemic preparedness, including how delayed recognition, limited field diagnostics, security concerns, misinformation, and strained international coordination affect the spread of an outbreak. They also discuss the importance of rapid diagnostics; strong epidemiology and contact tracing; reliable, high-containment laboratory networks; and sustained investment in vaccines, therapeutics, and broad-spectrum countermeasures, and emphasize the important role of community trust/local engagement, protection of health care workers, and global collaboration in controlling Ebola outbreaks and preparing for future threats.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Ebola Outbreak: Current Situation: US Centers for Disease Control and Prevention; [updated October 7, 2026]. Available from: https://www.cdc.gov/ebola/situation-summary/index.html.
2. Ebola Disease Outbreak in the Democratic Republic of the Congo: European Centre for Disease Prevention and Control; [updated October 8, 2026]. Available from: https://www.ecdc.europa.eu/en/ebola-outbreak-democratic-republic-congo-and-uganda.
3. A Risky Burial. Available from: https://www.nytimes.com/2026/07/01/world/africa/ebola-congo-burials.html.
4. Adepoju P. Research Response to the Bundibugyo Ebolavirus Outbreak. The Lancet Microbe. doi: 10.1016/j.lanmic.2026.101524.
5. Ebola Vaccines: World Health Organization; [updated September 9, 2026]. Available from: https://www.who.int/news-room/questions-and-answers/item/ebola-vaccines.
6. Marburg Virus Disease: Sabin Vaccine Institute; [October 9, 2026]. Available from: https://www.sabin.org/our-impact/disease-focus-areas/marburg/.
7. Jordan Wright HS, Logan Banadyga. Antibodies Cross-Reactive with Bundibugyo Virus in Ferrets Vaccinated with Ebola Virus Vaccine. Emerging Infectious Diseases. 2026;32(8):4. doi: 10.3201/eid3208.260948.
8. Shoemaker TR, Balinandi S, Tumusiime A, Nyakarahuka L, Lutwama J, Mbidde E, Kofman A, Klena JD, Ströher U, Rollin PE, Nichol ST. Impact of Enhanced Viral Haemorrhagic Fever Surveillance on Outbreak Detection and Response in Uganda. The Lancet Infectious Diseases. 2018;18(4):373–5. doi: 10.1016/S1473-3099(18)30164-6.
9. David Blumenthal JAM. It’s Time to Treat Pandemics as Threats to National Security: STAT; 2026. Available from: https://www.statnews.com/2026/07/20/pandemics-national-security-threats/.